A low concentration of azithromycin inhibits the mRNA expression of N-acyl homoserine lactone synthesis enzymes, upstream of lasI or rhlI, in Pseudomonas aeruginosa

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 6, 2009, Pages 483-486

  Kai, Toshihiro ^a   Tateda, Kazuhiro ^b   Kimura, Soichiro ^b   Ishii, Yoshikazu ^b   Ito, Hideaki ^a   Yoshida, Hiroaki ^a   Kimura, Toru ^a   Yamaguchi, Keizo ^b  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL TOXIN; MESSENGER RNA; N ACYLHOMOSERINE LACTONE;

ARTICLE; BACTERIAL GENE; DNA MICROARRAY; DOWN REGULATION; DRUG MECHANISM; ENZYME REGULATION; LASI GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RHII GENE; RHIR GENE; RSAI GENE; VFT GENE;

ACYL-BUTYROLACTONES; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL PROTEINS; MICROARRAY ANALYSIS; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 71249096926     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.04.004     Document Type: Article

References (18)

1. Davies J.C. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev 3 (2002) 128-134
2. Hoiby N. Diffuse panbronchiolitis and cystic fibrosis: east meets west. Thorax 49 (1994) 531-532
3. Fujii T., Kadota J., Kawakami K., Iida K., Shirai R., Kaseda M., et al. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 50 (1995) 1246-1252
4. Keicho N., and Kudoh S. Diffuse panbronchiolitis: role of macrolides in therapy. Am J Respir Med 1 (2002) 119-131
5. Kudoh S., Azuma A., Yamamoto M., Izumi T., and Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157 (1998) 1829-1832
6. Mizukane R., Hirakata Y., Kaku M., Ishii Y., Furuya N., Ishida K., et al. Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. Antimicrob Agents Chemother 38 (1994) 528-533
7. Molinari G., Guzman C.A., Pesce A., and Schito G.C. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother 31 (1993) 681-688
8. Sofer D., Gilboa-Garber N., Belz A., and Garber N.C. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy 45 (1999) 335-341
9. Tateda K., Comte R., Pechere J.C., Kohler T., Yamaguchi K., and Van Delden C. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45 (2001) 1930-1933
10. Tateda K., Ishii Y., Kimura S., Horikawa M., Miyairi S., and Yamaguchi K. Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery?. J Infect Chemother 13 (2007) 357-367
11. Tateda K., Standiford T.J., Pechere J.C., and Yamaguchi K. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors. Curr Pharm Des 10 (2004) 3055-3065
12. Kadota J., Sakito O., Kohno S., Sawa H., Mukae H., Oda H., et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147 (1993) 153-159
13. Sakito O., Kadota J., Kohno S., Abe K., Shirai R., and Hara K. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 63 (1996) 42-48
14. Schuster M., Lostroh C.P., Ogi T., and Greenberg E.P. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol 185 (2003) 2066-2079
15. Wagner V.E., Bushnell D., Passador L., Brooks A.I., and Iglewski B.H. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J Bacteriol 185 (2003) 2080-2095
16. Heurlier K., Denervaud V., and Haas D. Impact of quorum sensing on fitness of Pseudomonas aeruginosa. Int J Med Microbiol 296 (2006) 93-102
17. Nalca Y., Jansch L., Bredenbruch F., Geffers R., Buer J., and Haussler S. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 50 (2006) 1680-1688
18. Skindersoe M.E., Alhede M., Phipps R., Yang L., Jensen P.O., Rasmussen T.B., et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52 (2008) 3648-3663